100 Days
What if it took 100 days to make a safe and effective vaccine against any virus? We could stay one step ahead of infectious diseases and outbreaks could be stopped before they ever spiralled into pandemics.
Join us for the next 100 days, as we build towards our pandemic preparedness Summit in March, 2022. We will explore what it will take for the world to develop, and enable access to, safe and effective vaccines against new pathogens in 100 days and why it is crucial that the world achieves this 100 Days Mission.
Every day that passes after a viral threat is identified is critical. So, imagine a world that worked together to stop emerging viruses before they ever had the chance to turn into a pandemic…
Imagine if we had global surveillance networks able to detect new pathogens
Imagine if a library of vaccines could be used against these potential threats
Imagine if we had technologies that could produce safe, effective vaccines against any virus
Imagine if the world could rapidly produce and distribute enough vaccine to stop an outbreak from becoming a pandemic
Imagine if global clinical trials of these vaccines could be started in a matter of days
We want to help make this vision a reality. CEPI has an ambitious $3.5 billion equitable access-focussed R&D plan that will help the world create safe and effective vaccines in 100 days…
Global surveillance networks
International viral surveillance networks will need to be established that can alert global authorities to emerging epidemic threats and swiftly share genetic and disease information to trigger vaccine development.
Prototype vaccine library
The world must produce a library of prototype vaccines and other biological interventions against the viral families known to infect people. This will enable rapid adaptation of these prototype vaccines for clinical testing and evaluation of safety and effectiveness.
Rapid-response vaccine technology
Rapid response technologies must be developed, which can be quickly adapted to develop vaccines against the next Disease X.
Boosting vaccine manufacturing
Global manufacturing capacity needs to be in place, particularly in lower income countries. New approaches to manufacturing need to be advanced to produce vaccines at the speed and scale needed to stamp out a pandemic threat.
Trial and regulatory procedures
A global network of clinical trial sites, labs, and a globally agreed set of “rules” for trials in a pandemic situation needs to be established. These trial approaches will help to streamline data sharing and vaccine approvals by regulators.
Architects of Change
The world must urgently work together to outpace emerging viral threats. If we unite across countries and across the public and private sectors, we can make pandemics a thing of the past. Join us.